JDM Financial Group’s Avanos Medical AVNS Stock Holding History

JDM Financial Group’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-12	Closed	-$191	–	307
2024 Q4	$191	Hold	12	–	–	﹤0.01%	334
2024 Q3	$288	Buy	+12	New	+$274	﹤0.01%	400

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JDM Financial Group's AVNS Position: Q1 2025 in Review

JDM Financial Group sold out of Avanos Medical (AVNS) in Q1 2025, closing a stake of 12 shares — an estimated $191 sold.

JDM Financial Group first reported a position in AVNS in Q3 2024 and held it in 2 quarters. The position peaked at $288 in Q3 2024. 277 funds tracked by Wall St. Rank hold AVNS as of Q1 2025.

JDM Financial Group reported no remaining Avanos Medical position as of Q1 2025 after selling out during the quarter.
JDM Financial Group sold 12 Avanos Medical shares in Q1 2025, an estimated $191.
JDM Financial Group first reported a position in Avanos Medical in Q3 2024 and held it in 2 quarters.
JDM Financial Group's Avanos Medical position peaked at $288 in Q3 2024.
277 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2025.

Based on JDM Financial Group's 13F filing for Q1 2025, filed 15 May 2025.